Willingness to pay for cancer prevention versus treatment in China: implications for cost-effectiveness threshold
- 29 September 2023
- journal article
- research article
- Published by Taylor & Francis in Expert Review of Pharmacoeconomics & Outcomes Research
- Vol. 24 (1) , 155-160
Abstract
BackgroundEmpirical support for the appropriate cost-effectiveness threshold (CET) in China remains sparse.ObjectiveThis study aimed to estimate the willingness to pay (WTP) for cancer prevention and treatment from the perspective of healthcare policy-makers (i.e. supply side) and to investigate whether there is a difference between the estimated WTP in two scenarios.MethodsWe conducted a web-based survey from May to July 2022 among experts who offering consultation to the government. We surveyed 79 experts from a national think-tank (84.81% response rate) using contingent valuation method, a method for estimating the monetary value that individuals place on a non-market service.ResultsThe mean WTP for two scenarios were estimated at 1.29 times of per capita Gross Domestic Product (GDP) of China and 1.90 times of per capita GDP, respectively. There was a difference between the WTP in the two scenarios and the WTP for treatment was significantly higher than prevention.ConclusionThe findings suggest that though there is a smaller gap between the two scenarios in China as compared to other countries, the WTP may vary under different scenarios. So there's a need to further refine the development of CET by adding parameters like prevention instead of defining one universal threshold.Keywords
Funding Information
- Scientific Research Foundation of Nanjing University of Chinese Medicine
This publication has 34 references indexed in Scilit:
- The impact of the design of payment scales on the willingness to pay for health gainsThe European Journal of Health Economics, 2016
- Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost EffectivenessPharmacoEconomics, 2015
- Health-Related Quality of Life and Willingness to Pay per Quality-Adjusted Life-Year Threshold—A Study in Patients with Epilepsy in ChinaValue in Health Regional Issues, 2015
- A Systematic Review of Studies Eliciting Willingness-to-Pay per Quality-Adjusted Life Year: Does It Justify CE Threshold?PLOS ONE, 2015
- Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY ThresholdNew England Journal of Medicine, 2014
- WTP for a QALY and health states: More money for severer health states?Cost Effectiveness and Resource Allocation, 2013
- Willingness to Pay per Quality-Adjusted Life Year: Is One Threshold Enough for Decision-Making?Medical Care, 2011
- Willingness to Pay for a Quality-Adjusted Life-Year: The Individual PerspectiveValue in Health, 2010
- Healthcare Rationing by ProxyPharmacoEconomics, 2010
- The Rule of RescueSocial Science & Medicine, 2003